Masako Ishiguro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Masako Ishiguro has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Hiroshi Iwasaki
1 shared publication- Hiroshi Iwasaki
Department of Pathology, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 814-0180, Japan,
1 shared publication - Jun Nishio
Section of Orthopaedic Surgery, Department of Medicine, Fukuoka Dental College, 2-15-1 Tamura, Sawara-ku, Fukuoka 814-0193, Japan
1 shared publication - Kazuki Nabeshima
Fukuoka Tokushukai Hospital, Department of Diagnostic Pathology Pathological Diagnosis Center Fukuoka Japan
1 shared publication - Masatoshi Naito
Department of Orthopaedic Surgery, Faculty of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan
1 shared publication - Teruto Isayama
Department of Orthopaedic Surgery, Yanagawa Rehabilitation Hospital, 113-2 Kamimiyanaga-Machi, Yanagawa City, Fukuoka 832-0058, Japan
1 shared publication
Latest Publications
- Open Access
- 24 November 2010
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 29 (1) , 153
Establishment of a new human pleomorphic malignant fibrous histiocytoma cell line, FU-MFH-2: molecular cytogenetic characterization by multicolor fluorescence in situ hybridization and comparative genomic hybridization
Pleomorphic malignant fibrous histiocytoma (MFH) is one of the most frequent malignant soft tissue tumors in adults. Despite the considerable amount of research on MFH cell lines, their characterization at a molecular cytogenetic level has not been extensively analyzed.
- 24 November 2010
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 29 (1) , 153
Open AccessEstablishment of a new human pleomorphic malignant fibrous histiocytoma cell line, FU-MFH-2: molecular cytogenetic characterization by multicolor fluorescence in situ hybridization and comparative genomic hybridization
Pleomorphic malignant fibrous histiocytoma (MFH) is one of the most frequent malignant soft tissue tumors in adults. Despite the considerable amount of research on MFH cell lines, their characterization at a molecular cytogenetic level has not been extensively analyzed.
- 1 June 2004
- Published by Spandidos Publications in Oncology Reports
- Vol. 11 (6) , 1169-1175
Establishment and characterization of a renal cell carcinoma cell line (FU-UR-1) with the reciprocal ASPL-TFE3 fusion transcript.
We have established a cultured cell line named FU-UR-1 from a large retroperitoneal tumor of a 24-year-old Japanese male patient who simultaneously had a small renal cell carcinoma (RCC). Cytogenetic analysis and fluorescence in situ hybridization of the retroperitoneal tumor, and the cell line established from this tumor demonstrated similar karyotypes including add(13)(p11).ish der(13)t(13;17) (p11;q11)t(X;17)(p11;q25)(wcpX+,wcp17+). FU-UR-1 had been propagated continuously for more than 70 passages, and the doubling time was 32 h. Successful heterotransplantation was performed by inoculation of the cultured FU-UR-1 cells into the subcutis of BALB/c nude mice. Reverse transcriptase-polymerase chain reaction (RT-PCR) and sequence analysis demonstrated reciprocal ASPL-TFE3 and TFE3-ASPL fusion transcripts in the retroperitoneal tumor, cultured FU-UR-1 cells and xenografted tumors. In addition, the pathological findings of these samples and the renal tumor resembled each other. These observations suggest that the FU-UR-1 cell line established from the retroperitoneal tumor is an RCC cell line. This well-examined cell line may become a useful system for studying the genetic and biologic characteristics of rare neoplasms with the reciprocal ASPL-TFE3 fusion transcript.
- 1 June 2004
- Published by Spandidos Publications in Oncology Reports
- Vol. 11 (6) , 1169-1175
Establishment and characterization of a renal cell carcinoma cell line (FU-UR-1) with the reciprocal ASPL-TFE3 fusion transcript.
We have established a cultured cell line named FU-UR-1 from a large retroperitoneal tumor of a 24-year-old Japanese male patient who simultaneously had a small renal cell carcinoma (RCC). Cytogenetic analysis and fluorescence in situ hybridization of the retroperitoneal tumor, and the cell line established from this tumor demonstrated similar karyotypes including add(13)(p11).ish der(13)t(13;17) (p11;q11)t(X;17)(p11;q25)(wcpX+,wcp17+). FU-UR-1 had been propagated continuously for more than 70 passages, and the doubling time was 32 h. Successful heterotransplantation was performed by inoculation of the cultured FU-UR-1 cells into the subcutis of BALB/c nude mice. Reverse transcriptase-polymerase chain reaction (RT-PCR) and sequence analysis demonstrated reciprocal ASPL-TFE3 and TFE3-ASPL fusion transcripts in the retroperitoneal tumor, cultured FU-UR-1 cells and xenografted tumors. In addition, the pathological findings of these samples and the renal tumor resembled each other. These observations suggest that the FU-UR-1 cell line established from the retroperitoneal tumor is an RCC cell line. This well-examined cell line may become a useful system for studying the genetic and biologic characteristics of rare neoplasms with the reciprocal ASPL-TFE3 fusion transcript.